Infectious Disease Aerobiology, Division of Microbiology, Tulane National Primate Research Center, Covington, Louisiana, USA.
Southwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, Texas, USA.
J Aerosol Med Pulm Drug Deliv. 2022 Jan;35(1):50-56. doi: 10.1089/jamp.2021.0030. Epub 2021 Oct 6.
Bacillus Calmette-Guérin (BCG) is a vaccine used to protect against tuberculosis primarily in infants to stop early infection in areas of the world where the disease is endemic. Normally administered as a percutaneous injection, BCG is a live significantly attenuated bacteria that is now being investigated for its potential within an inhalable vaccine formulation. This study investigates the feasibility and performance of two jet and two vibrating mesh nebulizers aerosolizing BCG and the resulting particle characteristics and residual viability of the bacteria postaerosolization. A jet nebulizer (Collison), outfitted either with a 3- or 6-jet head, was compared with two clinical nebulizers, the vibrating mesh Omron MicroAir and Aerogen Solo devices. Particle characteristics, including aerodynamic particle sizing, was performed on all devices within a common aerosol chamber configuration and comparable BCG innocula concentrations. Integrated aerosol samples were collected for each generator and assayed for bacterial viability using conventional microbiological technique. A batch lot of BCG (Danish) was grown to titer and used in all generator assessments. Aerosol particles within the respirable range were generated from all nebulizers at four different concentrations of BCG. The jet nebulizers produced a uniformly smaller particle size than the vibrating mesh devices, although particle concentrations by mass were similar across all devices tested with the exception of the Aerogen Solo, which resulted in a low concentration of BCG aerosols. The resulting measured viable BCG aerosol concentration fraction produced by each device approximated one another; however, a measurable decrease of efficiency and overall viability reduction in the jet nebulizer was observed in higher BCG inoculum starting concentrations, whereas the vibrating mesh nebulizer returned a remarkably stable viable aerosol fraction irrespective of inoculum concentration.
卡介苗(BCG)是一种用于预防结核病的疫苗,主要用于世界上结核病流行地区的婴儿,以阻止早期感染。通常作为皮内注射,BCG 是一种活的、显著减毒的细菌,目前正在研究其作为可吸入疫苗制剂的潜力。本研究调查了两种射流和两种振动网孔雾化器雾化卡介苗的可行性和性能,以及雾化后细菌的颗粒特性和残余活力。
一种射流雾化器(Collison),配备 3 或 6 个射流头,与两种临床雾化器,即振动网孔 Omron MicroAir 和 Aerogen Solo 设备进行了比较。所有设备都在一个共同的气溶胶室配置和可比的卡介苗接种浓度下进行了颗粒特性,包括空气动力学粒径测定。对每个发生器进行了集成气溶胶采样,并使用常规微生物技术对细菌活力进行了测定。
一批卡介苗(丹麦)生长到滴度,并用于所有发生器评估。在四个不同浓度的卡介苗下,所有雾化器都能产生可吸入范围内的气溶胶颗粒。射流雾化器产生的颗粒尺寸比振动网孔装置均匀小,尽管所有测试设备的颗粒浓度(以质量计)相似,但 Aerogen Solo 除外,它产生的卡介苗气溶胶浓度很低。
每个设备产生的可测量的活菌卡介苗气溶胶浓度分数彼此近似;然而,在较高的卡介苗接种起始浓度下,射流雾化器的效率和整体活菌减少明显降低,而振动网孔雾化器无论接种浓度如何,都能返回一个相当稳定的活菌气溶胶分数。